Growth retardation in early-onset inflammatory bowel disease: Should we monitor and treat these patients differently?

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 404-411

  Griffiths, Anne M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chronic undernutrition; Inflammatory bowel disease; Pro inflammatory cytokines

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYTOKINE; GONADORELIN; GROWTH HORMONE; MERCAPTOPURINE; METHOTREXATE; SOMATOMEDIN C; TRANSCRIPTION FACTOR PIT 1; TUMOR NECROSIS FACTOR ANTIBODY;

CALORIC RESTRICTION; CONFERENCE PAPER; CROHN DISEASE; DELAYED PUBERTY; DRUG EFFICACY; ENTERIC FEEDING; ENTERITIS; GASTROINTESTINAL SURGERY; GENETIC SUSCEPTIBILITY; GROWTH RETARDATION; HUMAN; MALNUTRITION; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; ULCERATIVE COLITIS;

AGE OF ONSET; GROWTH DISORDERS; HUMANS; INFLAMMATORY BOWEL DISEASES; MONITORING, PHYSIOLOGIC; PUBERTY;

EID: 70349916518     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228581     Document Type: Conference Paper

References (40)

1. Rogol AD, Roemmich JN, Clark PA: Growth at puberty. J Adolesc Health 2002; 31: 192-200.
2. Griffiths AM, Nguyen P, Smith C, MacMillan H, Sherman PM: Growth and clinical course of children with Crohn's disease. Gut 1993; 34: 939-943. (Pubitemid 23203116)
3. Pfefferkorn M, Burke G, Griffiths A, et al: Growth abnormalities persist in newly diagnosed children with Crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr 2009;48:168-174.
4. Kirschner BS: Growth and development in chronic inflammatory bowel disease. Acta Paediatr Scand Suppl 1990;366: 98-104. (Pubitemid 20188338)
5. Kanof ME, Lake AM, Bayless TM: Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology 1988; 95: 1523-1527.
6. Hildebrand H, Karlberg J, Kristiansson B: Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994; 18: 165-173. (Pubitemid 24056474)
7. Markowitz J, Grancher K, Rosa J, Aiges H, Daum F: Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993; 16: 373-380. (Pubitemid 23143764)
8. Sawczenko A, Sandhu BK: Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003; 88: 995-1000. (Pubitemid 37449406)
9. Wine E, Reif SS, Leshinsky-Silver E, et al: Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics 2004; 114: 1281-1286. (Pubitemid 41647689)
10. Ballinger A: Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002; 58(suppl 1):7-10. (Pubitemid 35316829)
11. Walters TD, Griffiths AM: Mechanisms of growth impairment in Crohn's disease. Nat Pract Clin Gastroenterol, in press.
12. De Benedetti F, Meazza C, Oliveri M, et al: Effect of IL-6 on IGF binding protein-3:a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 2001; 142: 4818-4826. (Pubitemid 33022357)
13. De Benedetti F, Alonzi T, Moretta A, et al: Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: A model for stunted growth in children with chronic inflammation. J Clin Invest 1997; 99: 643-650. (Pubitemid 27097665)
14. Kelts DG, Grand FJ, Shen G, Watkins JB, Werlin SL, Boehme C: Nutritional basis of grwoth failure in children and adolescents with Crohn's disease. Gastroenterology 1979; 76: 720-727. (Pubitemid 9162969)
15. Ballinger A, Elh-Haj T, Perrett, et al: The role of the medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology 2000; 118: 544-553. (Pubitemid 30140852)
16. Azcue M, Rashid M, Griffiths A, Pencharz PB: Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997; 41: 203-208. (Pubitemid 27395923)
17. Martensson K, Chrysis D, Savendahl L: Interleukin- 1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J Bone Miner Res 2004; 19: 1805-1812. (Pubitemid 41103431)
18. Varghese S, Wyzga N, Griffiths AM, Sylvester FA: Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr 2002; 35: 641-648. (Pubitemid 35417735)
19. Ballinger AB, Savage MO, Sanderson I: Delayed puberty associated with inflammatory bowel disease. Pediatr Res 2003; 53: 205-210. (Pubitemid 36177114)
20. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MJ: Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut 2000; 46: 694-700. (Pubitemid 30305788)
21. Allen DB: Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective. Acta Paediatr 1998; 87: 123-129.
22. Levine A, Shamir R, Wine E, et al: TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease. Am J Gastroenterol 2005; 100: 1598-1604. (Pubitemid 41032370)
23. Sawczenko A, Azooz O, Paraszczuk J, et al: Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci USA 2005; 102: 13260-13265. (Pubitemid 41325011)
24. Griffiths AM, Otley AR, Hyams J, et al: A review of activity indices and end points for clinical trials in children with Crohn's disease. Inflamm Bowel Dis 2005; 11: 185-196. (Pubitemid 40711224)
25. Griffiths AM, Nicholas D, Smith C, et al: Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999; 28:S46-S52. (Pubitemid 30349269)
26. Walker-Smith JA: Management of growth failure in Crohn's disease. Arch Dis Child 1996; 75: 351-354. (Pubitemid 26354613)
27. Hyams JS, Crandall W, Kugathasan S, Griffiths AM, Olson A, Baldassano R, and the REACH Study Group: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007; 132: 863-873. (Pubitemid 46454266)
28. Fell JM, Paintin M, Arnaud-Battandier F, et al: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289. (Pubitemid 30145315)
29. Heuschkel RB, Menache CC, Megerian JT, Baird AE: Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15. (Pubitemid 30456568)
30. Belli DC, Seidman E, Bouthillier L, et al: Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94: 603-610. (Pubitemid 18073519)
31. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A: Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-548. (Pubitemid 26111374)
32. Seidman E, Jones A, Issenman R: Cyclical exclusive enteral nutrition versus alternate day prednisone in maintaining remission of pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 1996; 23:A344.
33. Kundhal P, Zachos M, Holmes JL, Griffiths AM: Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth. J Pediatr Gastroenterol Nutr 2001; 33: 75-80. (Pubitemid 32706128)
34. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F: A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902. (Pubitemid 30777909)
35. Turner D, Grossman A, Rosh J, Kugathasan S, Gilman AR, Baladassano R, Griffiths AM: Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol 2007; 102: 2804-2812. (Pubitemid 350179322)
36. Walters TD, Gilman AR, Griffiths AM: Linear growth improves during infliximab therapy in children with chronically active severe Crohn disease. Inflamm Bowel Dis 2007; 13: 424-430.
37. Griffiths AM, Wesson DE, Shandling B, Corey M, Sherman PM: Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut 1991; 32: 491-495.
38. Baldassano RN, Han PD, Jeshion WC, et al: Pediatric Crohn's disease: risk factors for postoperative recurrence. Am J Gastroen terol 2001; 96: 2169-2176. (Pubitemid 32660914)
39. Mauras N, George D, Evans J, et al: Growth hormone has anabolic effects in glucocorticosteroid- dependent children with inflammatory bowel disease: a pilot study. Metabolism 2002; 51: 127-135.
40. D'Haens D, Baert F, van Aasche G, et al: Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial. Lancet 2008;371:660-667. (Pubitemid 351284485)